Podimo 45 Tage kostenlos testen Ein Universum voller exklusiver Podcasts und Hörbücher. Klicken Sie hier um loszulegen!

CCO Oncology Podcast

Ein Podcast von: Clinical Care Options

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes

Our American listeners can also listen to CCO Oncology Podcast at our American site

168 Folgen

Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer
Vom 2024-03-28

Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer
Vom 2024-03-18
Current Considerations for Adverse Event Management With HER3-Directed Agents
Vom 2023-12-26
Unpacking the Potential of HER3-Targeted Therapy in NSCLC
Vom 2023-12-26
Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer
Vom 2023-12-26
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Vom 2023-12-04
Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis
Vom 2023-11-30
A Year in Review and a Look to the Future: BTKi in CLL and MCL
Vom 2023-11-20
Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Vom 2023-11-17
Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer
Vom 2023-11-07
Improving Care for Black Patients With Endometrial Cancer
Vom 2023-11-06
Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
Vom 2023-10-13
New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023
Vom 2023-10-04
New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023
Vom 2023-08-17
New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023
Vom 2023-07-28
Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers
Vom 2023-06-22
Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers
Vom 2023-05-04
Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma
Vom 2023-04-26
Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts
Vom 2023-04-11
BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges
Vom 2023-04-05

168 Folgen

Homologous Recombination Repair (HRR) Testing and Targeted Therapy in Prostate Cancer

Real-world Perspectives on Novel HER2-Targeted and TROP-2–Directed Therapies in Advanced Breast Cancer

Current Considerations for Adverse Event Management With HER3-Directed Agents

Unpacking the Potential of HER3-Targeted Therapy in NSCLC

Recent Advances in ADCs and Rationale for HER3 as a Target in Lung Cancer

Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis

A Year in Review and a Look to the Future: BTKi in CLL and MCL

Expert Insight on Key Updates and New Clinical Trial Data From the ESMO 2023 Congress Informing Treatment for Endometrial, Ovarian, and Cervical Cancers

Expert Insights and Considerations for Precision Care With HER3-Targeted Agents in NSCLC and Breast Cancer

Improving Care for Black Patients With Endometrial Cancer

Expert Insight on Key Updates and New Clinical Trial Data From the ESGO 2023 Congress Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

New Evidence With BTK Inhibitor Therapy in CLL and MCL From SOHO 2023

New Evidence With BTK Inhibitor Therapy in MCL From ICML 2023

New Evidence With BTK Inhibitor Therapy in CLL From EHA 2023

Expert Insight on Key Updates and New Clinical Trial Data From the 2023 ASCO Annual Meeting, Informing Treatment for Cervical, Ovarian, and Endometrial Cancers

Expert Insight on New Data From SGO 2023 Informing Treatment for Endometrial, Cervical, and Ovarian Cancers

Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

Contemporary Approaches to Treating Myelofibrosis: A Conversation Between Experts

BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges